Optiver Holding
DBTX

Optiver Holding’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Optiver Holding’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-867
Closed -$7K – 921
2021
Q4 		$7K Hold
867
– – ﹤0.01% 746
2021
Q3 		$7K Hold
867
– – ﹤0.01% 609
2021
Q2 		$7K Buy
+867
New +$7.65K ﹤0.01% 476

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Optiver Holding's DBTX Position: Q1 2022 in Review

Optiver Holding sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q1 2022, closing a stake of 867 shares — an estimated $7K sold.

Optiver Holding first reported a position in DBTX in Q2 2021 and held it in 3 quarters. The position peaked at $7K in Q4 2021. 39 funds tracked by Wall St. Rank hold DBTX as of Q1 2022.

  • Optiver Holding reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Optiver Holding sold 867 Decibel Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $7K.
  • Optiver Holding first reported a position in Decibel Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Optiver Holding's Decibel Therapeutics, Inc. Common Stock position peaked at $7K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Optiver Holding's 13F filing for Q1 2022, filed 16 May 2022.